WASHINGTON, Aug. 19, 2019 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that on August 16 2019, it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) as part of its ongoing review of Vanda's supplemental New Drug Application (sNDA) for HETLIOZ® (tasimelteon) for the treatment

LOS ANGELES, Aug. 19, 2019 /PRNewswire/ -- Launched in The New York Times Magazine, Possible Plan (www.possibleplan.org) is a new organization set to become a 501(c)3 that will facil

ISFIYA, Israel, Aug. 19, 2019 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKW), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of the C-Scan® System, the first and only preparation-free ingestible scanning c

DENVER, Aug. 19, 2019 /PRNewswire/ -- DAVITA INC. (NYSE: DVA), "DaVita," a Fortune 500® health care provider focused on transforming care delivery to improve quality of life for patients around the globe and the largest provider of kidney care services in the U.S., announced today the preliminary results of its modified "Dutch aucti

MARLBOROUGH, Mass., Aug. 19, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the completion of its acquisition of BTG plc. (LSE: BTG) pursuant to the previously announced scheme of arrangement. BTG develops and commercializes products used in minimally-invasive procedures targeting cancer and vascular diseases, as well as specialty pharmace

SUZHOU, China, Aug. 19, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616) today announced that an abstract on the company's ongoing CS1001-101 Phase Ib clinical study has been accepted for poster presentation at the upcoming European Society for Medical Oncology (ESMO) 2019 Annual Congress.CS1001 is an investigational anti-PD-L1 monoclonal antibod

- Acute Myeloid Leukaemia (AML): Preliminary Phase II clinical shows promising efficacy for bemcentinib in combo with low-intensity chemo in elderly AML patients unfit for intensive therapy- Non small cell lung cancer (NSCLC): Phase II clinical data continues to show promising clinical activity and improved overall survival, particularly in patients with AXL positive tumours including those with low or no PD-L1 expression.

WINDSOR LOCKS, Conn., Aug. 18, 2019 /PRNewswire/ -- Last weekend S.M.A.R.T. had a conference in Connecticut. https

KT-Ghana Deal Is First GEPP Service Outside Korea Ghana Will Upgrade Capacity to Handle Infectious Diseases KT Technologies Address Global Human Welfare Issues SEOUL, South Korea, Aug. 18, 2019 /PRNewswire/ -- KT Corp. (KRX: 030200; NYSE: KT) said its Global Epidemic Prevention Platform (

TAMPA, Fla., Aug. 16, 2019 /PRNewswire/ -- Link Home Care Services, cutting-edge LHCSA and CDPAP provider out of New York, selects Savii Inc. as their home care software platform. Their partnership formed due to shared values and desire to drive innovation in the home care industry.